MedPath

The Impact of Bariatric Surgery on Adipocyte Metabolism

Not Applicable
Active, not recruiting
Conditions
Obesity
Metabolic Syndrome
Interventions
Behavioral: Circadian Clock Control
Behavioral: Circadian Clock Alignment
Registration Number
NCT04242524
Lead Sponsor
University of Chicago
Brief Summary

The purpose of this study is to understand how daily rhythms of behavior affect the expression of genes in fat cells, and how these daily cycles affect the way fat cells respond to insulin (a hormone that controls blood sugar levels) before and after bariatric surgery.

Detailed Description

Bariatric surgery as a means of weight loss has become increasingly popular over the last 10-15 years. In addition to promoting weight loss, bariatric surgery has become increasingly recognized for use in the management of diabetes. Recent studies have indicated that bariatric surgery can result in a marked improvement in insulin sensitivity before long term weight loss is attained. The goal of this project is to delineate the changes in the insulin responsiveness of subcutaneous adipocytes obtained by needle biopsy 2 weeks prior to surgery vs. 12 weeks after bariatric surgery, which could account for improvements in overall insulin sensitivity seen before any long-term sustained weight loss has occurred. The investigators will also examine gene expression in adipocytes (fat cells).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
82
Inclusion Criteria
  • 18-55 years old
  • Female
  • BMI greater than 40 kg/m2
  • Scheduled for bariatric surgery at the Center for the Surgical Treatment of Obesity at the University of Chicago
  • Signed informed consent
Exclusion Criteria
  • Male
  • Diagnosed with a systemic illnesses, including heart, renal, liver, or malignant disease
  • Uncontrolled hypertension (blood pressure greater than 140 mmHg systolic and 90 mmHg diastolic without medication)
  • use of beta blockers
  • hemoglobin less than 11.5g/dL
  • known allergy to lidocaine
  • pregnancy
  • lactation
  • Subjects will not have undergone surgery, donated a unit of blood, or participated in another clinical study within the last 4 weeks prior to consent.
  • Post-menopausal

Non-Obese Subjects

Inclusion Criteria:

  • 18-55 years old
  • Female
  • BMI less than 30 kg/m2
  • Signed informed consent

Exclusion Criteria:

  • Male
  • Diagnosed with a systemic illnesses, including heart, renal, liver, or malignant disease
  • Uncontrolled hypertension (blood pressure greater than 140 mmHg systolic and 90 mmHg diastolic without medication)
  • use of beta blockers
  • hemoglobin less than 11.5g/dL
  • known allergy to lidocaine
  • pregnancy
  • lactation
  • Subjects will not have undergone surgery, donated a unit of blood, or participated in another clinical study within the last 4 weeks prior to consent.
  • Post-menopausal

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Circadian Clock Control - Low BMICircadian Clock ControlSubjects will not come to the Sleep Lab and will live normally at home with no changes to their meal, sleep or wake times.
Circadian Clock Alignment - High BMICircadian Clock AlignmentSubjects will come to the Sleep Lab three nights before their bariatric surgery procedure for an intervention that will align their central circadian clock. The intervention includes eating meals and snacks at fixed times and having lights off at a specific time at night and lights on at a specific time in the morning.
Circadian Clock Control - High BMICircadian Clock ControlSubjects will not come to the Sleep Lab and will live normally at home with no changes to their meal, sleep or wake times.
Primary Outcome Measures
NameTimeMethod
Change in insulin sensitivity12 weeks

Insulin sensitivity will be measured as the by the phosphorylation level of Akt in adipocytes (fat cells) at baseline and 12 weeks post bariatric surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath